Respiratory Virus Infections during the COVID-19 Pandemic Revealed by Multiplex PCR Testing in Japan
- PMID: 36723071
- PMCID: PMC10100992
- DOI: 10.1128/spectrum.04162-22
Respiratory Virus Infections during the COVID-19 Pandemic Revealed by Multiplex PCR Testing in Japan
Abstract
Under the strict quarantine policy imposed to combat the COVID-19 (coronavirus disease 2019) pandemic in Japan, the prevalence of respiratory infections by viruses other than SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) has been largely unknown. However, such information on viral circulation is important in order to develop better management policies that are based on scientific data. Here, we retrospectively investigated respiratory virus infections in individuals who visited a community hospital with respiratory symptoms between June of 2020 and September of 2021 with the use of the BioFire FilmArray Respiratory Panel 2.1. Virus was detected in 65 out of a total of 328 subjects, with SARS-CoV-2 (67.7%), rhino/enterovirus (18.5%), and parainfluenza virus 3 (7.7%) accounting for most of the infections. No influenza virus or respiratory syncytial virus (RSV) infections were detected. The monthly cases of rhino/enterovirus infection were highest from winter to spring, with this temporal pattern differing from that of SARS-CoV-2. SARS-CoV-2 was detected more frequently (P < 0.001) in subjects with cough (31/104 cases, 29.8%) than in those without cough (13/224 cases, 5.8%), suggesting that cough might contribute to the prediction of COVID-19. Our findings also suggest that testing for rhino/enterovirus and parainfluenza virus 3, in addition to SARS-CoV-2, may be important for the rigorous diagnosis of respiratory virus infections. IMPORTANCE Influenza virus, RSV, adenovirus, and rhino/enterovirus were the major respiratory viruses before COVID-19 pandemic. Circulating respiratory viruses may have been affected by our strong quarantine policy during the COVID-19 pandemic. We checked the circulating respiratory viruses from our outpatients by using a multiplex PCR kit that had recently been released. SARS-CoV-2 was the most frequently detected virus, and it was followed by rhino/enterovirus and parainfluenza virus 3. No influenza virus or RSV infections were detected during our study period, suggesting that influenza virus and RSV became almost extinct. COVID-19 cases frequently experienced cough, and this frequency was statistically significantly higher than that observed in the cases without SARS-CoV-2 detection. The cough can be an indicator of COVID-19.
Keywords: COVID-19; FilmArray; SARS-CoV-2; coronavirus; multiplex PCR; respiratory virus.
Conflict of interest statement
The authors declare no conflict of interest.
Figures



Similar articles
-
Epidemiology of respiratory tract infections using multiplex PCR in a Japanese acute care hospital during the COVID19 pandemic.Heliyon. 2023 Mar 11;9(3):e14424. doi: 10.1016/j.heliyon.2023.e14424. eCollection 2023 Mar. Heliyon. 2023. PMID: 36919088 Free PMC article.
-
Evaluation of Three Multiplex Real-time Reverse Transcription PCR Assays for Simultaneous Detection of SARS-CoV-2, Influenza A/B, and Respiratory Syncytial Virus in Nasopharyngeal Swabs.J Korean Med Sci. 2021 Dec 13;36(48):e328. doi: 10.3346/jkms.2021.36.e328. J Korean Med Sci. 2021. PMID: 34904407 Free PMC article.
-
Acute Respiratory Tract Infections (ARTIs) in Children after COVID-19-Related Social Distancing: An Epidemiological Study in a Single Center of Southern Italy.Diagnostics (Basel). 2024 Jun 25;14(13):1341. doi: 10.3390/diagnostics14131341. Diagnostics (Basel). 2024. PMID: 39001232 Free PMC article.
-
Assessing respiratory viral exclusion and affinity interactions through co-infection incidence in a pediatric population during the 2022 resurgence of influenza and RSV.Front Cell Infect Microbiol. 2023 Jun 14;13:1208235. doi: 10.3389/fcimb.2023.1208235. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 37389220 Free PMC article. Review.
-
Epidemiology, Clinical Significance, and Diagnosis of Respiratory Viruses and Their Co-Infections in the Post-COVID Era.Pathogens. 2025 Mar 7;14(3):262. doi: 10.3390/pathogens14030262. Pathogens. 2025. PMID: 40137747 Free PMC article. Review.
Cited by
-
Changes in Viral Dynamics Following the Legal Relaxation of COVID-19 Mitigation Measures in Japan From Children to Adults: A Single Center Study, 2020-2023.Influenza Other Respir Viruses. 2024 Mar;18(3):e13278. doi: 10.1111/irv.13278. Influenza Other Respir Viruses. 2024. PMID: 38513611 Free PMC article.
-
The effect of infectious diseases on lung transplantation in Japan.J Thorac Dis. 2024 Feb 29;16(2):1632-1644. doi: 10.21037/jtd-22-1884. Epub 2024 Feb 27. J Thorac Dis. 2024. PMID: 38505071 Free PMC article. Review.
-
Surveillance of Respiratory Pathogens Among Rapid Diagnostic Test-Negative Acute Respiratory Infection Patients in Myanmar in 2023, with a Focus on Rhinovirus and Enterovirus Genotyping.Viruses. 2025 Jun 17;17(6):860. doi: 10.3390/v17060860. Viruses. 2025. PMID: 40573450 Free PMC article.
References
-
- Zhou P, Yang X-L, Wang X-G, Hu B, Zhang L, Zhang W, Si H-R, Zhu Y, Li B, Huang C-L, Chen H-D, Chen J, Luo Y, Guo H, Jiang R-D, Liu M-Q, Chen Y, Shen X-R, Wang X, Zheng X-S, Zhao K, Chen Q-J, Deng F, Liu L-L, Yan B, Zhan F-X, Wang Y-Y, Xiao G-F, Shi Z-L. 2020. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579:270–273. doi:10.1038/s41586-020-2012-7. - DOI - PMC - PubMed
-
- Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R, Niu P, Zhan F, Ma X, Wang D, Xu W, Wu G, Gao GF, Tan W. China Novel Coronavirus Investigating and Research Team. 2020. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 382:727–733. doi:10.1056/NEJMoa2001017. - DOI - PMC - PubMed
-
- Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, Perez JL, Pérez Marc G, Moreira ED, Zerbini C, Bailey R, Swanson KA, Roychoudhury S, Koury K, Li P, Kalina WV, Cooper D, Frenck RW, Hammitt LL, Türeci Ö, Nell H, Schaefer A, Ünal S, Tresnan DB, Mather S, Dormitzer PR, Şahin U, Jansen KU, Gruber WC. 2020. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med 383:2603–2615. doi:10.1056/NEJMoa2034577. - DOI - PMC - PubMed
-
- Uriu K, Kimura I, Shirakawa K, Takaori-Kondo A, Nakada T-A, Kaneda A, Nakagawa S, Sato K. Genotype to Phenotype Japan (G2P-Japan) Consortium. 2021. Neutralization of the SARS-CoV-2 mu variant by convalescent and vaccine serum. N Engl J Med 385:2397–2399. doi:10.1056/NEJMc2114706. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous